Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trialMaarten Groenink, B. J. M. Mulder, Jean‐Pierre Timmermans et al.|European Heart Journal|2013Cited by 396
Beneficial Outcome of Losartan Therapy Depends on Type of <i>FBN1</i> Mutation in Marfan SyndromeRomy Franken, Gerard Pals, Alexander W. den Hartog et al.|Circulation Cardiovascular Genetics|2015Cited by 165
Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trialMaarten Groenink, Barbara J.M. Mulder, Teodora Radonic et al.|Trials|2010Cited by 88
Emerging Biomarkers and the Changing Landscape of Small Cell Lung CancerAnna Keogh, Teodora Radonic|Cancers|2022Cited by 45